The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 13, 2021
Filed:
Apr. 24, 2015
Applicant:
University of Massachusetts, Boston, MA (US);
Inventors:
Guangping Gao, Westborough, MA (US);
Phillip D. Zamore, Northborough, MA (US);
Shaoyong Li, Hopkinton, MA (US);
Assignee:
University of Massachusetts, Boston, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2006.01); C12N 15/113 (2010.01); A61K 31/713 (2006.01); C12N 7/00 (2006.01); C12N 15/117 (2010.01); A61K 38/17 (2006.01); A61K 38/28 (2006.01); A61K 38/44 (2006.01); A61K 38/48 (2006.01); A61K 38/51 (2006.01); A61K 48/00 (2006.01); C07K 16/10 (2006.01); C07K 16/22 (2006.01); C07K 16/28 (2006.01); C07K 16/32 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 38/1709 (2013.01); A61K 38/28 (2013.01); A61K 38/446 (2013.01); A61K 38/4846 (2013.01); A61K 38/51 (2013.01); A61K 48/0008 (2013.01); C07K 16/10 (2013.01); C07K 16/22 (2013.01); C07K 16/2875 (2013.01); C07K 16/2887 (2013.01); C07K 16/32 (2013.01); C12N 7/00 (2013.01); C12N 15/113 (2013.01); C12N 15/117 (2013.01); C12N 2310/141 (2013.01); C12N 2310/17 (2013.01); C12N 2320/30 (2013.01); C12N 2330/51 (2013.01); C12N 2710/10322 (2013.01); C12N 2710/10332 (2013.01); C12N 2750/14143 (2013.01); C12N 2760/00042 (2013.01); C12N 2830/008 (2013.01); C12Y 115/01001 (2013.01); C12Y 304/21022 (2013.01); C12Y 401/01028 (2013.01);
Abstract
The disclosure in some aspects, relates to nucleic acids, compositions and kits useful for gene therapy with reduced immune response to transgene products.